郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line.

期刊：Journal of neurochemistry发表年份：2007作者：Barbara Bosier; Sébastien Tilleux; Mustapha Najimi; Didier M Lambert; Emmanuel Hermans
阅读更多 →

药效评价A novel recombinant, VPAC2-selective agonist enhancing insulin release and glucose disposal.

期刊：Acta pharmacologica Sinica发表年份：2007作者：Rong-jie Yu; Ngai-lik Tam; Yuan Gao; Zhi-hong Zeng; Tian-hong Zhou; An Hong
阅读更多 →

药效评价Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.

期刊：Journal of medicinal chemistry发表年份：2007作者：Scott D Kuduk; Christina N Di Marco; Ronald K Chang; Michael R Wood; Kathy M Schirripa; June J Kim; Jenny M C Wai; Robert M DiPardo; Kathy L Murphy; Richard W Ransom; C Meacham Harrell; Duane R Reiss; Marie A Holahan; Jacquelynn Cook; J Fred Hess; No
阅读更多 →

药效评价Differential intracellular signaling through PAC1 isoforms as a result of alternative splicing in the first extracellular domain and the third intracellular loop.

期刊：Molecular pharmacology发表年份：2007作者：Mina Ushiyama; Ryuji Ikeda; Hideki Sugawara; Morikatsu Yoshida; Kenji Mori; Kenji Kangawa; Kazuhiko Inoue; Katsushi Yamada; Atsuro Miyata
阅读更多 →